1. Home
  2. VRDN vs LKFN Comparison

VRDN vs LKFN Comparison

Compare VRDN & LKFN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VRDN
  • LKFN
  • Stock Information
  • Founded
  • VRDN 2006
  • LKFN 1872
  • Country
  • VRDN United States
  • LKFN United States
  • Employees
  • VRDN N/A
  • LKFN N/A
  • Industry
  • VRDN Medical Specialities
  • LKFN Major Banks
  • Sector
  • VRDN Health Care
  • LKFN Finance
  • Exchange
  • VRDN Nasdaq
  • LKFN Nasdaq
  • Market Cap
  • VRDN 1.6B
  • LKFN 1.8B
  • IPO Year
  • VRDN N/A
  • LKFN 1997
  • Fundamental
  • Price
  • VRDN $13.48
  • LKFN $59.44
  • Analyst Decision
  • VRDN Buy
  • LKFN Hold
  • Analyst Count
  • VRDN 12
  • LKFN 1
  • Target Price
  • VRDN $36.44
  • LKFN $74.00
  • AVG Volume (30 Days)
  • VRDN 766.3K
  • LKFN 178.2K
  • Earning Date
  • VRDN 05-07-2025
  • LKFN 04-25-2025
  • Dividend Yield
  • VRDN N/A
  • LKFN 3.33%
  • EPS Growth
  • VRDN N/A
  • LKFN N/A
  • EPS
  • VRDN N/A
  • LKFN 3.63
  • Revenue
  • VRDN $302,000.00
  • LKFN $236,773,000.00
  • Revenue This Year
  • VRDN N/A
  • LKFN $12.76
  • Revenue Next Year
  • VRDN $17,629.40
  • LKFN $5.18
  • P/E Ratio
  • VRDN N/A
  • LKFN $16.60
  • Revenue Growth
  • VRDN N/A
  • LKFN N/A
  • 52 Week Low
  • VRDN $11.40
  • LKFN $57.45
  • 52 Week High
  • VRDN $27.20
  • LKFN $78.61
  • Technical
  • Relative Strength Index (RSI)
  • VRDN 32.50
  • LKFN 29.71
  • Support Level
  • VRDN $14.03
  • LKFN $59.81
  • Resistance Level
  • VRDN $15.91
  • LKFN $61.40
  • Average True Range (ATR)
  • VRDN 0.67
  • LKFN 1.24
  • MACD
  • VRDN -0.10
  • LKFN 0.01
  • Stochastic Oscillator
  • VRDN 6.51
  • LKFN 25.92

About VRDN Viridian Therapeutics Inc.

Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate VRDN-001 is an insulin-like growth factor-1 receptor (IGF-1R) monoclonal antibody (mAb) being developed for the potential treatment for patients with thyroid eye disease.

About LKFN Lakeland Financial Corporation

Lakeland Financial Corp is a bank holding company. It provides commercial, retail, wealth advisory, and investment management services. Lakeland offers a broad range of products and services throughout its Northern and Central Indiana markets. The company offers commercial and consumer banking services, as well as trust and wealth management, brokerage, and treasury management commercial services. It serves a wide variety of industries including, among others, commercial real estate, manufacturing, agriculture, construction, retail, wholesale, finance and insurance, accommodation and food services, and healthcare.

Share on Social Networks: